Vertex’s Next-in-class Triple Combo Therapy for Cystic Fibrosis Gets FDA Priority Review
The drug candidate "raises the high bar set by Trikafta," according to Vertex Pharma's executive vice president and chief regulatory and quality officer.
Tag: Vertex Pharma
All
Latest
All
Latest
Vertex’s Cystic Fibrosis Pill Gets European Medicines Agency’s Backing
Vertex Pharmaceutical's triple combination cystic fibrosis treatment, Kaftrio, is one step closer to coming to market after receiving a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).
All
LatestCorbus Looks to Take on Vertex with Experimental CF Drug
Corbus, a small biopharmaceutical company, received $5 million from the Cystic Fibrosis Foundation last month to develop the drug, Resunab.
Cystic Fibrosis Foundation and Vertex to Brief Congress on Cutting-Edge Venture-Philanthropy Model
Nonprofits across the country are increasingly funding promising, early-stage drug research to advance treatments for life-threatening diseases.
Read More